MADIT-CRT Trial Meets Primary Endpoint (dvances in indications in the CRM space ...)

MADIT-CRT Trial Meets Primary Endpoint

Date:6/23/2009

dvances in indications in the CRM space through trials like MADIT-CRT. More than 80 percent of U.S. patients who receive an ICD or CRT-D were first indicated for this therapy by a clinical trial sponsored by Boston Scientific or its predecessors(3)."

MADIT-CRT is providing insight into the potential of CRT-D therapy to intervene earlier in the natural progression of heart failure. Currently, patients must be in NYHA Class III/IV heart failure to be indicated for CRT-D therapy. However, approximately 70 percent of all heart failure patients in the U.S. fall into Class I or II. Nearly 22 million people worldwide, including approximately 5.5 million Americans, suffer from some form of heart failure.

Boston Scientific is a worldwide developer, manufacturer and marketer of medical devices whose products are used in a broad range of interventional medical specialties. For more information, please visit: www.bostonscientific.com.

Cautionary Statement Regarding Forward-Looking Statements

This press release contains forward-looking statements within the meaning of Section 21E of the Securities Exchange Act of 1934. Forward-looking statements may be identified by words like "anticipate," "expect," "project," "believe," "plan," "estimate," "intend" and similar words. These forward-looking statements are based on our beliefs, assumptions and estimates using information available to us at the time and are not intended to be guarantees of future events or performance. These forward-looking statements include, among other things, statements regarding our product performance, clinical outcomes, regulatory approval of our products, and our growth strategy. If our underlying assumptions turn out to be incorrect, or if certain risks or uncertainties materialize, actual results could vary materially from the expectations and projec
'/>"/>

SOURCE Boston Scientific Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4
Related medicine technology :

1. DIA Annual Meeting Attendees Invited to Participate in Electronic Data Capture (EDC) Clinical Trial Survey
2. Amicus Therapeutics Commences Phase 3 Trial Evaluating Amigal(TM) for the Treatment of Fabry Disease
3. Responses After Completion of Therapy Increase Pixantrone Complete Remission (CR)/Unconfirmed Complete Remission (CRu) Rate to 24% and Overall Response Rate (ORR) to 40% Compared to 7% and 14% for Comparator Agents in Phase III EXTEND Trial in 3rd Line Th
4. ProFibrix Initiates Phase II Clinical Trial of its Lead Topical Hemostat Product Fibrocaps(TM)
5. CuraGen Announces Expansion of CR011-vcMMAE Phase II Trial in Advanced Breast Cancer
6. HEALTHPOINT-Sponsored Venous Leg Ulcer Clinical Trial Enrolls First Subject for Second Phase II Study
7. MacroGenics and Lilly Achieve Targeted Patient Enrollment in PROTEGE, a Global Phase 2/3 Clinical Trial of Teplizumab in Type 1 Diabetes
8. New Legislation Seeks to Boost Participation in Clinical Trials for Rare Diseases
9. VIA Pharmaceuticals Meets With FDA to Discuss Next Steps For VIA-2291 and Phase 3 Outcome Trial in Cardiovascular Disease
10. Osteotech Completes Enrollment for DuraTech(TM) BioRegeneration Matrix Clinical Trial
11. DOR BioPharma Receives EMEA Agreement on the Design of its Confirmatory Phase 3 Clinical Trial of orBec(R) in GI GVHD

Post Your Comments:

(Date:5/20/2013)... -- Uroplasty, Inc. (Nasdaq: UPI ) announced today ... fourth quarter and full year ended March 31, 2013 ... The Company will host a conference call and webcast ... at 4:30 p.m. Eastern Time (3:30 p.m. Central Time). ... dial 888-549-7750, no passcode is necessary. To access the ...

(Date:5/20/2013)... May 20, 2013 /PRNewswire-iReach/ -- It is no secret that ... being overweight or obese gyms and supplement companies are in ... condition is primarily related to dietary issues and a lack ... result of a glandular problem or even a vitamin deficiency. ... vitamin deficiency is a lack of vitamin b12 . ...

(Date:5/20/2013)... , May 20, 2013 National Community ... Hoey , RPh, MBA issued the following statement ... Associates regarding Medicare Part D "preferred pharmacy" drug ... offering patients the plan,s lowest advertised co-payments: ... Medicare and MedPAC , 16 ...

Breaking Medicine Technology:Uroplasty To Announce Fiscal Fourth Quarter And Full Year 2013 Financial Results On May 30, 2013 2 USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss 2 Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 2 Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 3 Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans 4

[0] Uroplasty To Announce Fiscal Fourth Quarter And Full Year 2013 Financial Results On May 30, 2013 [0] USB12Shots.com Discusses the Possibility of B12 Shots for Weight Loss [0] Poll: Over One Million Seniors Have Problems with Medicare 'Preferred Pharmacy' Drug Plans

... YORK, July 4, 2011 Reportlinker.com ... report is available in its catalogue: ... Global Pipeline Analysis, Competitive Landscape and ... http://www.reportlinker.com/p0567378/Gastrointestinal-Endoscopes---Global-Pipeline-Analysis-Competitive-Landscape-and-Market-Forecasts-to-2017.html#utm_source=prnewswire&utm_medium=pr&utm_campaign=Medical_Imaging ...

... VisionGate, Inc., a company developing a ... cancer, today announced that it will present data showing ... the utility of low dose x-ray computed tomography (CT) ... high risk individuals. LuCED uses VisionGate,s revolutionary automated 3D ...

Gastrointestinal Endoscopes - Global Pipeline Analysis, Competitive Landscape and Market Forecasts to 2017 VisionGate to Present at IASLC Meeting Showing How Adjunctive Use of Its 3D Cell Imaging Platform Can Increase Utility of CT Screening for Lung Cancer

(Date:5/20/2013)... 2013 Dorland Health, a division ... fourth annual Case In Point Platinum Awards, recognizing ... ensuring the system is patient- and family-centric, safe ... and creative work across the healthcare system that ... transitions of care through effective care coordination across ...

(Date:5/20/2013)... May 20, 2013 National law firm Parker ... Thrash Law Firm P.A., both based in Little Rock, Arkansas ... the proposed $7.25 billion settlement of a price-fixing case against ... objection was filed Wednesday, May 15, 2013, in the U.S. ... related lawsuit against Visa and MasterCard (Case No. 1:05-md-1720) is ...

(Date:5/20/2013)... is proud to announce the publication of the much-anticipated ... A. Weinberg. , The First Edition has been ... the most important advances in the fast-growing field of ... all of its hallmark features admired by students, instructors, ... of Cancer is a textbook for students studying the ...

(Date:5/20/2013)... For more than forty years, Narconon rehab ... drug and alcohol abuse around the world. Now, Narconon ... to help Italian speakers reverse growing trends in cannabis ... Centre for Drugs and Drug Addiction show that among ... the last year. As a glimpse of where things ...

(Date:5/20/2013)... whose mother lived near heavy traffic while pregnant faces ... before the age of 3, a new study suggests. ... of mothers and infants from eastern Massachusetts. All the ... of pregnancy at some point between 1999 and 2002. ... 100 meters (about 110 yards) from a major roadway, ...

Breaking Medicine News(10 mins):Health News:Dorland Health Announces the 2013 Case In Point Platinum Awards Winners 2 Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 2 Health News:Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’ 3 Health News:'The Biology of Cancer' by Robert A. Weinberg 2 Health News:First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth 2 Health News:Living Near Major Roadways in Pregnancy Tied to Respiratory Woes in Children 2

[0] Dorland Health Announces the 2013 Case In Point Platinum Awards Winners [0] Parker Waichman LLP Takes on the Credit Card Companies, Fights for Smaller Retailers that Form the U.S. Economy’s ‘Backbone’[0] 'The Biology of Cancer' by Robert A. Weinberg [0] First Narconon Cannabis Abuse Prevention Guide Takes Aim at Drug Abuse Statistics for Italian Youth [0] Living Near Major Roadways in Pregnancy Tied to Respiratory Woes in Children

... that have shifted funds away from tobacco control programs ... a new study co-authored by San Francisco State University ... funded at the levels recommended by the Centers for ... astonishing 14-20 times more than the cost of implementing ...

... Maureen Salamon HealthDay Reporter , WEDNESDAY, Nov. 23 ... a simple way to avoid packing on holiday pounds: Eat ... and men chow down faster than women, two new studies ... plays in quantity of food consumed, researchers from the University ...

... low risk pregnancies should be able to choose where they ... it shows that first-time mums who opt for a home ... overall risk is low in all birth settings. The ... with low risk pregnancies a choice of birth setting" and ...

... Jenifer Goodwin HealthDay Reporter , WEDNESDAY, Nov. ... are hospitalized for adverse drug reactions yearly, and most ... new study finds. The four types of medication ... account for two-thirds of those drug-related emergency hospitalizations. ...

... By Maureen Salamon HealthDay Reporter , WEDNESDAY, Nov. ... known that genes account for much of a person,s height. ... missing copies of certain genes, which can leave them significantly ... children and adults, an international team of researchers learned that ...

... Reporter , TUESDAY, Nov. 22 (HealthDay News) -- The U.S. ... pay $950 million to resolve investigations into its marketing of ... in 2004 after studies revealed the drug increased users, risks ... $321.6 million in criminal fines and $628.4 million as a ...

Cached Medicine News:Health News:States could see substantial savings with tobacco control programs 2 Health News:Could Slow Eating Be Key to Staying Slim? 2 Health News:Could Slow Eating Be Key to Staying Slim? 3 Health News:Pregnant women at low risk of complications can safely be offered a choice of where to give birth 2 Health News:Four Common Meds Send Thousands of Seniors to Hospital: CDC 2 Health News:Four Common Meds Send Thousands of Seniors to Hospital: CDC 3 Health News:Gene Shortage Might Lead to Shorter Height, Study Says 2 Health News:Merck to Pay $950M to Settle Probe of Vioxx Marketing 2 Health News:Merck to Pay $950M to Settle Probe of Vioxx Marketing 3

States could see substantial savings with tobacco control programs Could Slow Eating Be Key to Staying Slim? Pregnant women at low risk of complications can safely be offered a choice of where to give birth Four Common Meds Send Thousands of Seniors to Hospital: CDC Gene Shortage Might Lead to Shorter Height, Study Says Merck to Pay $950M to Settle Probe of Vioxx Marketing

... 2000 is a unique microprocessor controlled shaking ... in either 96 or 384 well format. ... the control panel and all are displayed ... under the clear protective cover. The Millennium ...

The BD LSR II can be configured with up to four fixed alignment lasers and the ability to detect up to 15 colors, utilizing a revolutionary optical design. The BD LSR II can be configured with a 488 ...

Multiparameter laser and arc lamp flow cytometer for all applications in immunology, microbiology, cell biology, pathology, hematology, lymphocyte dubset and cell analysis....

... flow cytometer for any kind of ... The CyFlow SL analyzes forward and ... up to 3 fluorescence channels. Data ... performed with a PC or laptop ...

Medicine Products:

Millennium 2000 Microplate Shaker Incubator BD LSR II System Particle Analysing System PAS CyFlow SL